TCI GENE Inc. (6879.TWO)
TWD 41.0
(-14.58%)
TWD 41.0
(-14.58%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.16 Billion TWD | 0.22% |
| 2022 | 1.16 Billion TWD | 107.62% |
| 2021 | 560.31 Million TWD | 77.69% |
| 2020 | 315.33 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.22 Billion TWD | 0.0% |
| 2024 Q1 | 1.22 Billion TWD | 4.84% |
| 2023 FY | 1.16 Billion TWD | 0.22% |
| 2023 Q2 | 1.2 Billion TWD | 0.0% |
| 2023 Q1 | 1.2 Billion TWD | 3.4% |
| 2023 Q3 | 1.16 Billion TWD | -3.07% |
| 2023 Q4 | 1.16 Billion TWD | 0.0% |
| 2022 Q4 | 1.16 Billion TWD | 0.0% |
| 2022 Q3 | 1.16 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -810.556% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 59.808% |
| Level Biotechnology Inc. | 822.67 Million TWD | -41.726% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -75.402% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -112.473% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 70.057% |
| GlycoNex Incorporation | 1.55 Billion TWD | 24.914% |
| VBI | 452.1 Million TWD | -157.893% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 0.867% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -55.755% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -208.155% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -2.831% |
| Visgeneer Inc. | 397.17 Million TWD | -193.558% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 69.076% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 45.997% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -32.029% |
| Neith Corporation | 192.15 Million TWD | -506.777% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 80.863% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1485.062% |
| Enimmune corporation | 604.82 Million TWD | -92.772% |
| TaiRx, Inc. | 833.74 Million TWD | -39.844% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 62.219% |
| EirGenix Inc. | 11.16 Billion TWD | 89.555% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -103.431% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 31.91% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 67.583% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -10.991% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -287.314% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -340.548% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -164.271% |
| RBC Bioscience Corporation | 753.79 Million TWD | -54.677% |
| BiOptic Inc. | 613.77 Million TWD | -89.963% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 34.449% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -0.537% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -80.808% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 62.465% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -688.149% |
| NaviFUS Corp. | 490.53 Million TWD | -137.687% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 4.877% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 14.481% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -120.344% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -0.392% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 29.605% |
| AP Biosciences Inc | 890.75 Million TWD | -30.893% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 86.327% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -259.694% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 12.575% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 56.993% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 92.411% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -184.197% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -193.798% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 43.835% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -295.796% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 14.479% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -23.804% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -66.932% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 70.512% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 69.499% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 5.196% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 79.194% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -9.786% |
| Acepodia, Inc. | 6.81 Billion TWD | 82.9% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 69.53% |